← Back to Search

Nicotine Replacement Therapy

Text Messaging + Nicotine Replacement for Smoking Cessation

N/A

Waitlist Available

Led By Alana Rojewski, PhD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month follow-up

Awards & highlights

Study Summary

This trial will test a new way to help patients follow through with lung cancer screenings, by giving them medication and sending them text messages.

Who is the study for?

This trial is for smokers aged 55 or older with a significant smoking history (30 pack years), who are willing to try quitting and can communicate in English. They must not be using other cessation programs, have serious heart issues, recent heart attacks, unstable mental health conditions, severe alcohol or substance abuse problems.Check my eligibility

What is being tested?

The study is testing if adding medication and text messaging support helps people quit smoking better than the usual care given during lung cancer screenings. Participants will either receive this new combination treatment or the standard care randomly.See study design

What are the potential side effects?

Potential side effects from nicotine replacement therapy may include skin irritation from patches, sleep disturbances if used before bedtime, mouth soreness with lozenges/gum, and nausea. Text messaging has no known medical side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

End of Treatment Abstinence Rates

Secondary outcome measures

End of Study Abstinence Rates

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Treatment ArmExperimental Treatment1 Intervention

Advice to quit and brief discussion of tobacco use plus dual nicotine replacement therapy plus 8 weeks of gain-framed text messages tailored to lung cancer screening patients

Group II: Standard CareActive Control1 Intervention

Advice to quit and brief discussion of tobacco use

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Text messaging plus nicotine replacement therapy

2019

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

937 Previous Clinical Trials

7,396,810 Total Patients Enrolled

Alana Rojewski, PhDPrincipal InvestigatorMedical University of South Carolina

1 Previous Clinical Trials

367 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what degree is the capacity of this research study being stretched?

"Affirmative. The clinical trial information on clinicialtrials.gov shows that this study is actively seeking volunteers, with the original posting date being April 15th 2019 and a recent edit having been made on April 21st 2022. 80 participants are needed at one location for successful completion of the study."

Answered by AI

Can any additional individuals join the experimental cohort?

"As per clinicaltrials.gov, this scientific trial is still open for patient enrollment. It was initially published on April 15th 2019 and the most recent update occurred in 2021 on the 21st of April."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Tobacco Treatment in the Context of Lung Cancer Screening

2019. "Tobacco Treatment in the Context of Lung Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03927989.